Varian Medical Systems Given Average Rating of “Hold” by Analysts (NYSE:VAR)
Varian Medical Systems (NYSE:VAR) has earned a consensus rating of “Hold” from the ten analysts that are presently covering the stock, American Banking & Market News reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $87.22.
In other Varian Medical Systems news, CFO Elisha W. Finney unloaded 5,000 shares of the company’s stock on the open market in a transaction dated Thursday, August 7th. The stock was sold at an average price of $83.95, for a total transaction of $419,750.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Shares of Varian Medical Systems (NYSE:VAR) opened at 85.21 on Monday. Varian Medical Systems has a 52-week low of $70.10 and a 52-week high of $87.85. The stock has a 50-day moving average of $84.04 and a 200-day moving average of $82.61. The company has a market cap of $8.794 billion and a P/E ratio of 21.88.
Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, July 23rd. The company reported $1.08 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.09 by $0.01. The company had revenue of $747.70 million for the quarter, compared to the consensus estimate of $767.52 million. During the same quarter last year, the company posted $1.03 earnings per share. Varian Medical Systems’s revenue was up 3.0% compared to the same quarter last year. Analysts expect that Varian Medical Systems will post $4.27 EPS for the current fiscal year.
A number of analysts have recently weighed in on VAR shares. Analysts at Zacks reiterated a “neutral” rating on shares of Varian Medical Systems in a research note on Friday, July 25th. They now have a $88.00 price target on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Varian Medical Systems in a research note on Thursday, July 24th. They now have a $98.00 price target on the stock, up previously from $92.00. Finally, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Varian Medical Systems in a research note on Thursday, July 24th. They now have a $95.00 price target on the stock, up previously from $85.00.
Varian Medical Systems, Inc, is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.